Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating daily tadalafil at 2.5 mg and 5 mg for erectile dysfunction has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Cialis (tadalafil)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED